echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The reform of drug bidding in Guangdong Province

    The reform of drug bidding in Guangdong Province

    • Last Update: 2013-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2013-05-23 source: in order to further reduce the false high price of drugs, Guangdong will reform the drug bidding and trading methods this year According to the Department of health of Guangdong Province, five supporting documents have been issued for the relevant rules of drug trade in Guangdong Province (Draft for comments) According to the reform spirit and relevant work deployment of Guangdong Provincial Government on changing the mode of drug bidding and purchasing from "government led" to "government led, market operation", Guangdong will make full use of modern electronic information technology, create a centralized third-party drug electronic trading platform in Guangdong Province, and build“ Online bidding, online trading, online payment, online financing, online supervision "is a new mode of drug trading Through online bidding, volume price linkage and other measures, the virtual high price of drugs can be effectively reduced The rules are applicable to drug transactions of public medical institutions at county level and above and private medical institutions designated by medical insurance throughout the province, and other private medical institutions are encouraged to enter into the trading platform for drug transactions It is understood that trading drugs can be divided into four categories: basic drug varieties, medical insurance catalog varieties, non-medical insurance catalog varieties, low-cost drugs and clinically necessary and difficult varieties One of the features of the new regulation is to set up "market entry price" in the two categories of basic drug varieties and medical insurance catalog varieties, and the production enterprises conduct online bidding Among them, the average bid winning price of each province (autonomous region, municipality directly under the central government) of the same product specification of the same manufacturer (the lowest bid winning price of the country shall be taken for the product specification of exclusive production after the grouping of bidding varieties) and the bid winning price of centralized drug procurement of Guangdong Province in 2009 shall be taken as the market price The ex factory (port) price recorded by the manufacturer is for the reference of medical institutions in drug transaction The manufacturer conducts online bidding according to the purchase volume summarized by the trading platform, and the lowest quotation is the trading variety For the varieties of essential drugs, the average bid winning price of essential drugs of the same manufacturer in each province (autonomous region, municipality directly under the central government) of the country and the bid winning price of essential drugs in Guangdong in 2012 are taken as the market price Another new feature is the variety of the medical insurance catalogue and the variety of the basic drugs The mode of "joint procurement, online bidding, quantity price linkage" is implemented There are two modes of joint procurement that are independently selected by the medical institutions The first way is "the trading platform conducts group purchase according to the product planning summary" Each medical institution shall fill in the procurement volume of its own selected product specifications on the trading platform within the specified time The trading platform shall automatically summarize the procurement volume reported by the provincial medical institutions according to the product specifications every month, and announce the summarized procurement volume to the enterprise The second way is "group purchase by medical institutions" The medical institution independently forms a consortium, and the medical institution shall fill in the procurement volume of its selected product specification on the trading platform within the specified time The trading platform shall summarize and report the procurement volume according to the consortium, and announce the summarized procurement volume to the enterprise According to the new regulations, on the last working day of each month, the selected product regulations of the medical institutions in the whole province and the procurement volume summarized by each product regulation will be published on the Internet, and the relevant production enterprises will quote on the system according to the procurement volume published and reported, and the quotation shall not be higher than the market price The quotation is divided into three times and completed within one day Those who do not quote for the first time cannot participate in the subsequent quotation After each quotation, the trading platform will automatically prompt each manufacturer's quotation position (only the manufacturer's position can be seen) When modifying the quotation, it is required that the next quotation is lower than the previous one If not, it is not necessary to make another quotation The head of Guangdong Provincial Department of Health said that these two issues have indeed been fully taken into account First, all categories of medical insurance catalog are divided into different quality levels and grouped through online bidding The quality level of government priced drugs is determined according to the current effective pricing classification of the maximum retail price of drugs, which is divided into five categories: patent, original research, independent pricing, high quality and good price (including differential pricing), and GMP In this way, we can ensure that drugs of different levels and quality have different price assessment standards Second, low-cost drugs and clinically necessary and difficult procurement varieties include a small number of first-aid drugs (including blood products such as human albumin and antivenom serum), low-cost common drugs (according to the latest medical insurance catalog, drugs with daily average use cost ≤ 3 yuan), clinical special drugs and controlled drugs( Including narcotic drugs, class I and II psychotropic drugs, medical radiation drugs and toxic drugs for medical use under special management of the state) or drugs designated by the state for production The specific product regulations shall be announced separately The medical institutions directly select the manufacturers and product specifications, and the market price of the government priced varieties is the transaction price, without bidding or bargaining; the market regulated price varieties are negotiated by the medical institutions through the trading platform, and online trading is implemented  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.